These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 30485591)

  • 1. Cardiac contractility modulation: mechanisms of action in heart failure with reduced ejection fraction and beyond.
    Tschöpe C; Kherad B; Klein O; Lipp A; Blaschke F; Gutterman D; Burkhoff D; Hamdani N; Spillmann F; Van Linthout S
    Eur J Heart Fail; 2019 Jan; 21(1):14-22. PubMed ID: 30485591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Cardiac Contractility Modulation in Heart Failure With a Higher Ejection Fraction.
    Talha KM; Anker SD; Burkhoff D; Filippatos G; Lam CSP; Stone GW; Wazni O; Butler J
    J Card Fail; 2022 Dec; 28(12):1717-1726. PubMed ID: 36122819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac contractility modulation: a novel approach for the treatment of heart failure.
    Abi-Samra F; Gutterman D
    Heart Fail Rev; 2016 Nov; 21(6):645-660. PubMed ID: 27394714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac contractility modulation in patients with heart failure - A review of the literature.
    Bazoukis G; Saplaouras A; Efthymiou P; Yiannikourides A; Liu T; Letsas KP; Efremidis M; Lampropoulos K; Xydonas S; Tse G; Armoundas AA
    Heart Fail Rev; 2024 May; 29(3):689-705. PubMed ID: 38393423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction?
    Riccardi M; Sammartino AM; Adamo M; Inciardi RM; Lombardi CM; Pugliese NR; Tomasoni D; Vizzardi E; Metra M; Coats AJS; Pagnesi M
    Heart Fail Rev; 2023 Sep; 28(5):1141-1149. PubMed ID: 37198505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic science of cardiac contractility modulation therapy: Molecular and electrophysiological mechanisms.
    Masarone D; Kittleson MM; D'Onofrio A; Falco L; Fumarulo I; Massetti M; Crea F; Aspromonte N; Pacileo G
    Heart Rhythm; 2024 Jan; 21(1):82-88. PubMed ID: 37769793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced inotropic state of the failing left ventricle by cardiac contractility modulation electrical signals is not associated with increased myocardial oxygen consumption.
    Butter C; Wellnhofer E; Schlegl M; Winbeck G; Fleck E; Sabbah HN
    J Card Fail; 2007 Mar; 13(2):137-42. PubMed ID: 17395055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study.
    Liu M; Fang F; Luo XX; Shlomo BH; Burkhoff D; Chan JY; Chan CP; Cheung L; Rousso B; Gutterman D; Yu CM
    Int J Cardiol; 2016 Mar; 206():122-6. PubMed ID: 26788686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Contractility Modulation and Baroreflex Activation Therapy in Heart Failure Patients.
    Mann JA; Abraham WT
    Curr Heart Fail Rep; 2019 Feb; 16(1):38-46. PubMed ID: 30762177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure.
    Morita H; Suzuki G; Haddad W; Mika Y; Tanhehco EJ; Sharov VG; Goldstein S; Ben-Haim S; Sabbah HN
    J Card Fail; 2003 Feb; 9(1):69-75. PubMed ID: 12612875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of 5 versus 12 hours per day of cardiac contractility modulation treatment for heart failure patients: A preliminary report.
    Kloppe A; Mijic D; Schiedat F; Bogossian H; Mügge A; Rousso B; Lemke B
    Cardiol J; 2016; 23(1):114-9. PubMed ID: 26503077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac contractility modulation in heart failure with reduced ejection fraction treatment].
    Chugunov IA; Mareev YV; Fudim M; Mironova NA; Mareev VY; Davtyan RV
    Kardiologiia; 2022 Nov; 62(11):71-78. PubMed ID: 36521047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
    Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
    Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.
    Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P;
    Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.
    Hsu JJ; Ziaeian B; Fonarow GC
    JACC Heart Fail; 2017 Nov; 5(11):763-771. PubMed ID: 29032140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
    Katsi V; Georgiopoulos G; Laina A; Koutli E; Parissis J; Tsioufis C; Nihoyannopoulos P; Tousoulis D
    Heart Fail Rev; 2017 Nov; 22(6):641-655. PubMed ID: 28601914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.